DIAS - The diabetes advisory system: An outline of the system and the evaluation results obtained so far

Computer Methods and Programs in Biomedicine

Volumn 54, Issue 1-2, 1997, Pages 49-58

  Hejlesen, Ole K ^a   Andreassen, Steen ^a   Hovorka, Roman ^b   Cavan, David A ^c  

^a AALBORG UNIVERSITY   (Denmark)

^b CITY UNIVERSITY   (United Kingdom)

^c ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

Decision support system; Evaluation results; Insulin dependent diabetes mellitus; Insulin dosage adjustment

Indexed keywords

COMPUTER AIDED DIAGNOSIS; COMPUTER NETWORKS; CONTROLLED DRUG DELIVERY; GLUCOSE; HEALTH CARE; INSULIN; PROBABILITY;

CAUSAL PROBABILISTIC NETWORK; DIABETES ADVISORY SYSTEM (DIAS); INSULIN DEPENDENT DIABETES;

DECISION SUPPORT SYSTEMS;

CARBOHYDRATE; GLUCOSE; INSULIN; ISOPHANE INSULIN;

ALGORITHM; CARBOHYDRATE METABOLISM; COMPARTMENT MODEL; DRUG ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; INFORMATION SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; REVIEW;

EID: 0031239240     PISSN: 01692607     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-2607(97)00033-3     Document Type: Article

References (47)

1. DiabCard2: Improved communication in diabetes based on chip card technology - phase 2. AIM A2051.
2. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, New Engl. J. Med. 329 (1993) 977-986.
3. B.G. Bolli, A.M. Gale, Hypoglycaemia, in: K.G.M.M. Alberti, R.A. Defronzo, H. Keen, P. Zimmet (Eds.), International Textbook of Diabetes Mellitus, Wiley, Chichester, 1992, pp. 1131-1149.
4. C. Binder, E.R. Carson, S. Carey et al., A vision of information technology support for diabetes care, Diabetes Nutr. Metab. 8 (1995) 205-214.
5. A. Schiffrin, M. Mihic, B.S. Leibel, M. Albisser, Computer assisted insulin dosage adjustment, Diabetes Care 8 (1985) 545-552.
6. F.E. Harvey, E.R. Carson, Diabeta - an expert system for the management of diabetes, in: D.D. Tsiftsis (Ed.) Objective Medical Decision-Making: Systems Approach in Disease, Springer-Verlag, Berlin, 1986, pp. 166-174.
7. S.C. Chao, A.M. Albisser, The diabetes simulator, in: Decision Support for Patient Management: Measurement, Modelling and Control, British Medical Informatics Society, London, 1989, pp. 86-88.
8. T. Deutsch, E.R. Carson, F.E. Harvey, et al., Computer-assisted diabetic management: a complex approach, Comput. Methods Programs Biomed. 32 (1990) 195-214.
9. M.P. Berger, D. Rodbard, Computer simulation of plasma insulin and glucose dynamics after subcutaneous insulin injection, Diabetes Care 12 (1989) 725-736.
10. E. Salzsieder, G. Albrecht, U. Fischer, A. Rutscher, U. Thierbach, Computer-aided systems in the management of type I diabetes: the application of a model-based strategy, Comput. Methods Programs Biomed. 32 (1990) 215-224.
11. M.S. Leaning, M.A. Boroujerdi, A system for compartmental modelling and simulation, Comput. Methods Programs Biomed. 35 (1991) 71-92.
12. J. Schneider, K. Piwernetz, R. Engelbrecht, R. Renner, DIACONS - A consultation system to assist in the management of diabetes, in: O. Reinhoff, U. Piccolo, B. Schneider (Eds.) Expert Systems and Decision Support in Medicine, Springer-Verlag, Berlin, 1988, pp. 44-49.
13. M.P. Berger, R.A. Gelfand, P.L. Miller, Combining statistical, rule-based and physiologic model-based methods to assist in the management of diabetes mellitus, Comput. Biomed. Res. 23 (1990) 346-357.
14. E.D. Lehmann, T. Deutsch, A.V. Roudsari, E.R. Carson, J.J. Benn, P.H. Sonksen, A metabolic prototype to aid in the management of insulin treated diabetic patients, Diabetes Nutr. Metab. 4:1 (1991) 163-167.
15. M.A. Boroujerdi, C.D. Williams, E.R. Carson, K. Piwernetz, K.D. Hepp, P.H. Sonksen, Simulation approach for planning insulin regimes, in: P. Brunetti, W.K. Waldhaust (Eds.) Int. Symp. on Advanced Models for Therapy of Insulin-dependent Diabetes, Raven Press, New York, 1987, pp. 41-46.
16. M.A. Boroujerdi, M.S. Leaning, E. Nicolosi, Knowledge-rich representations of carbohydrate metabolism for diabetic expert systems, in: Medical Informatics 88: Computers in Clinical Medicine, British Medical Informatics Society, London, 1988, pp. 89-96.
17. J.J. Benn, S.J. Bozzard, D. Kelley, et al., Persistent abnormalities of the metabolism of an oral glucose load in insulin-treated type I diabetics, Metabolism 38 (1989) 1047-1055.
18. W.F. Ganong, Review of Medical Physiology, 11th ed., Lange, Los Altos, 1983, pp. 572-573.
19. J.J. Benn, R. Rai, P. Sonksen, Increased glucose carbon recycling in severely insulin deficient Type 1 (insulin-dependent) diabetic subjects, Diabetologia 33 (1990) 158-162.
20. I. Gottesman, L. Mandarino, J. Gerich, Estimation and kinetic analysis of insulin-independent glucose uptake in human subjects, Am. J. Physiol. 244 (1983) E632-E635.
21. R.A. Rizza, L.J. Mandarino, J.E. Gerich, Dose-response characteristics for effects of insulin on production and utilization of glucose in man, Am. J. Physiol. 240 (1981) E630-E639.
22. J.D. Best, G.J. Taborsky Jr., J.B. Halter, D. Porte Jr., Glucose disposal is not proportional to plasma glucose level in man, Diabetes 30 (1981) 847-850.
23. I. Gottesman, L. Mandarino, C. Verdonk, R. Rizza, J. Gerich, Insulin increases the maximum velocity for glucose uptake without altering the Michaelis constant in man, J. Clin. Invest. 70 (1982) 1310-1314.
24. I. Gottesman, L. Mandarino, J. Gerich, Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo, Diabetes 33 (1984) 184-191.
25. P.M. Bell, R.G. Firth, R.A. Rizza, Effects of hyperglycemia on glucose production and utilization in humans. Measurement with [23H]-, [33H]-, and [614C] glucose, Diabetes 35 (1986) 642-648.
26. C. Binder, Absorption of injected insulin, Acta Pharmacol. Toxicol. 27 (1969) 1-87.
27. K. Kolendorf, P. Aaby, S. Westergaard, T. Deckert, Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo), Eur. J. Clin. Pharmacol. 14 (1978) 117-124.
28. T. Lauritzen, S. Pramming, E.A.M. Gale, T. Deckert, C. Binder, Absorption of isophane (NPH) insulin and its clinical implications, Br. Med. J. 285 (1982) 159-161.
29. E.W. Kraegen, D.J. Chisholm, Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies, Diabetologia 26 (1984) 208-213.
30. C. Binder, T. Lauritzen, O. Faber, S. Pramming, Insulin pharmaco-kinetics, Diabetes Care 7 (1984) 188-199.
31. P. Hildebrandt, K. Birch, L. Sestoft, A.A. Volund, Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulin, Acta. Med. Scand. 215 (1984) 69-73.
32. D.R. Owen, Human Insulin - Clinical Pharmacological Studies in Normal Man, MTP Press, Lancaster, UK, 1986.
33. A. Vaag, K. Damgaard Pedersen, M. Lauritzen, P. Hildebrandt, H. Bech-Nielsen, Intramuscular versus subcutaneus injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus, Diabetic Med. 7 (1990) 335-342.
34. A. Vaag, A. Handberg, M. Lauritzen, J.E. Henriksen, K. Damgaard Pedersen, H. Bech-Nielsen, Variation in absorption of NPH insulin due to intramuscular injection, Diabetes Care 13 (1990) 74-76.
35. R. Hovorka, S. Andreassen, J.J. Benn, K.G. Olesen, E.R. Carson, Causal probabilistic network modelling - an illustration of its role in the management of chronic diseases, IBM Syst. J. 31 (1992) 635-648.
36. S. Andreassen, J.J. Benn, R. Hovorka, K.G. Olesen, E.R. Carson, A probabilistic approach to glucose prediction and insulin dose adjustment - description of a metabolic model and pilot evaluation study, Comput. Methods Programs Biomed. 41 (1994) 153-165.
37. O.K. Hejiesen, S. Andreassen, S.K. Andersen, Implementation of a learning procedure for multiple observations in a Diabetes Advisory System based on causal probabilistic networks, in: S. Andreassen, R. Engelbrecht, J. Wyatt (Eds.), Artificial Intelligence in Medicine, IOS Press, Amsterdam, 1993.
38. O.K. Hejiesen, S. Andreassen, S. K. Andersen, Dynamic propagation in causal probabilistic networks with instantiated variables, in: P. Barahona, M. Stefanelli, J. Wyatt (Eds.), Artificial Intelligence in Medicine, Springer, Berlin, 1995.
39. O.K. Hejiesen, S. Andreassen, S.H. Sando, Optimization and evaluation of a probabilistic computer model of the glucose metabolism, Appl. Med. Inform. 1 (1995) 11-24.
40. O.K. Hejiesen, S. Andreassen, D.A. Cavan, R. Hovorka, Analysing the hypoglycaemic counter-regulation: a clinically relevant phenomenon?, Comput. Methods Programs Biomed. 50 (1996) 231-240.
41. D.A Cavan, O. Hejiesen, R. Hovorka et al., A controlled trial of advice on insulin dose adjustments by the DIAS computer model - implications for management of insulin-dependent diabetes, submitted.
42. S. Andreassen, O.K. Hejlesen, N.E. Frandsen et al., Evaluation of a diabetes advisory system (DIAS) by a double blind controlled clinical trial: a necessary step?, in: Proc. Computers in Diabetes '96, Graz, Austria, 1996, p. 39.
43. O.K. Hejlesen. M. Rix, S. Andreassen et al., Evaluation of a diabetes advisory system in adolescents, Diabetologia, (1997) in press.
44. D.A. Cavan, R. Hovorka, O.K. Hejlesen, S. Andreassen, P.H. Sonksen, Use of the DIAS model to predict unrecognised hypoglycaemia in patients with insulin-dependent diabetes, Comput. Methods Programs Biomed. 50 (1996) 241-246.
45. M. Rix, S. Andreassen, O. Hejlesen, The dawn phenomenon in children with IDDM, confirmed by modelling of glucose metabolism, Proc. Computers in Diabetes '94, Heinrich Heine University, Düsseldorf, 1994, p. 37.
46. S. Andreassen, Prediction of blood glucose and adjustment of insulin doses by a metabolic model - SWAN, Proc. Computers in Diabetes '94, Karlovy Vary, Czechoslovakia, 1992, p. 4.
47. O.K. Hejlesen, S. Andreassen, R. Hovorka, D. Meeking, D.A. Cavan, Is the Somogyi effect due to reduced absorption of intermediate-acting insulin following hypoglycaemia?, Diabetic Medicine 13 (Suppl. 2) (1996) S37.